Inactive Instrument

Analyst Reco. Coloplast A/S Other OTC

Equities

COLOPLAST : Q1 24: Many more positives beyond the margin beat	02-14
COLOPLAST : EPS cut (2023: -12.9%, 2024: -14.7%)	01-04
COLOPLAST : Q4 23: more misses than hits	12-06
Chinese headwinds could be more severe than expected	22/09/23
Analyst recommendations: Hewlett Packard, Apple, Tesla, Mosaic, Rite Aid...	30/08/23
COLOPLAST : Q3 23: inflation still bites; FY23 margin miss likely	23/08/23
COLOPLAST : Q2 23: Inflation and supply chain headwinds continue to bite	11/05/23
Roadshow - Berenberg	09/02/23	FA
COLOPLAST : Q1 23: largely in line underlying trends even as interest costs bite	08/02/23
COLOPLAST : Q4 22: China weighs on performance; FY23 guidance fails to impress	16/11/22
COLOPLAST : Good Q3; China remains a near-term catalyst	24/08/22
COLOPLAST : Q1 22: guidance cut spooks investors	06/05/22
BNP Paribas Exane MedTech CEO Conference	28/03/22	FA
COLOPLAST : Good start to FY 22	27/01/22
Berenberg European Conference	05/12/21	FA
COLOPLAST : FY 22 guidance plays spoilsport	02/11/21
COLOPLAST : Positive strategic update offsets soft Q3 21 showing	19/08/21
ANALYST RECOMMENDATIONS : Accenture, Comcast, DoorDash, Intel, Roku...	25/06/21
Exane BNP Paribas European CEO Conference	09/06/21	FA
Berenberg US Conference	17/05/21	FA

No results for this search

COLOPLAST : Q1 24: Many more positives beyond the margin beat

February 14, 2024 at 04:08 pm